biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by unclepiemanon May 16, 2014 11:54am

169 Views

Post# 22570198

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:today's market

Problem is that BTI is too small for any real investment firm to want to even look at it, normally known firms dont look at anything with less than 1b cap (at least from what i know) so BTI doesnt even really exist.

all the more reasons for BTI to start getting proper NR and going out there and creating awareness

Bullboard Posts

Canadian government to fund Electric Royalties portfolio property